Bristol-Myers Squibb ( BMY ) has come on strong to finish off 2025. I was bullish on the now $110 billion market cap healthcare sector stock back in the third quarter , and shares have returned a solid 18%, dividend included, since then. That’s more thanFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My pas ...

Core Insights - MLP units have significantly underperformed compared to the S&P 500, with the S&P 500 SPDR ETF (SPY) increasing by 17% including dividends through Thanksgiving, while MLP units lag behind [1] Performance Comparison - The S&P 500 SPDR ETF (SPY) has shown a 17% increase through Thanksgiving, indicating strong market performance [1] Investment Context - The article highlights the disparity in performance between MLP units and broader market indices, suggesting potential implications for investors considering MLP investments [1]